March 29, 2021
The Honorable, the Senate:
hist130728I am vetoing Senate Bill 183 in its entirety. The bill provides a role for the Legislature in the expenditure of federal funds related to COVID-19 received b the state from the effective date of the bill until June 30, 2022. Specifically, the bill requires the Governor to submit a plan to the Joint Committee on Finance for any federal funds received by the state related to COVID-19 activities, subject to a 14+day passive review process.
I am vetoing the bill because it is critical to get the federal COVID-19 relief funds in the hands of Wisconsinites and businesses that need it as quickly as possible, and I have concerns that the process outlined in the bill will prevent that from happening. Under the bill, and objection by any committee member could hold up funding for an indeterminate amount of time, as happens not infrequently under the current 14-day passive review process. This would unnecessarily delay the distribution of these funds, many of which have to be distributed according to federal law and using existing formulas.
In Wisconsin, the role of the Governor to oversee use of federal funds under Section 16.54 of the Wisconsin Statutes is clearly established and has been in place for decades, a fact that as confirmed by legislative leadership in a letter they send to me in April 2020. At the same time, I understand the Legislature’s desire to know how the funding is being distributed and I am committee to transparency about our effort to meet the needs to Wisconsin’s citizens and businesses as quickly as possible. Respectfully submitted,
TONY EVERS
Governor
_____________
Referrals and Receipt of Committee Reports Concerning Proposed Administrative Rules
The joint committee for review of Administrative Rules reported and recommended:
Relating to certification for identification, removal, and reduction of lead-based paint hazards.
Relating to technical changes to update ETF rules.
Relating to administration of the crime victims compensation program.
Relating to requests for predeterminations regarding license eligibliity due to conviction records.
Relating to professional land surveyors licensure.
Relating to complex rehabilitation technology and certification.
Relating to designer permits.
Relating to biennial registration.
Relating to continuing podiatric medical education.
Relating to electric weapons.
Relating to scheduling MMB-FUBICA and 4F-MDMB-BINACA.
Relating to scheduling isotonitazene and 1P-LSD.
Relating to changes to rules governing substitute educational interpreter licenses.
Relating to certification courses for funeral director apprentices.
Relating to reciprocal credentials for service members, former service members, and their spouses.
Relating to reciprocal credentials for service members, former service members, and their spouses.
Relating to scheduling of brexanolone and solriamfetol.
Relating to scheduling of N-Ethylhexedrone, a-PHP, 4-MEAP, MPHP, PV8 and 4-chloro-a-PVP.
Relating to scheduling of noroxymorphone.
Relating to reciprocal credentials for service members, former service members, and their spouses.
Relating to private residence elevators.
STEPHEN NASS
Senate Chairperson
